Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Eunah | - |
dc.contributor.author | Kim, Kwangmeyung | - |
dc.contributor.author | Kwon, Ick Chan | - |
dc.date.accessioned | 2024-01-20T22:02:09Z | - |
dc.date.available | 2024-01-20T22:02:09Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 2009-02 | - |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/132774 | - |
dc.description.abstract | Molecular imaging is a bioimaging that can detect biochemically and genetically relevant events in molecular level in cells and tissues via quantitative imaging signal. Molecular imaging provides potential advantages to examine early diagnosis of specific diseases, to screen new candidates of a drug, to monitor therapeutic effects in real time, and to communicate with both diagnosis and therapeutics. These diverse advantages of molecular imaging can be allowed by development of nanoplatform technology. The nanoplatform-based probes for molecular imaging is widely investigated to grant multimodal molecular imaging and drug delivery together with medical imagings, which includes the issues of biocompatibility, targeting moiety, protease-specific peptide substrate, quenching/dequenching system etc. In this paper, nanoplatform-based probes are reviewed in aspects of cancer targeting for diagnosis and therapy and multimodal molecular imaging with inorganic/organic hybrid nanoparticles. | - |
dc.language | Korean | - |
dc.publisher | KOREAN MEDICAL ASSOC | - |
dc.subject | GLYCOL CHITOSAN NANOPARTICLES | - |
dc.subject | IN-VIVO | - |
dc.subject | PROTEASE ACTIVITY | - |
dc.subject | PROBE | - |
dc.subject | ATHEROSCLEROSIS | - |
dc.subject | VISUALIZATION | - |
dc.subject | TOMOGRAPHY | - |
dc.title | Multifunctional Nanoparticles for Molecular Imaging | - |
dc.type | Article | - |
dc.identifier.doi | 10.5124/jkma.2009.52.2.125 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, v.52, no.2, pp.125 - 134 | - |
dc.citation.title | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.citation.volume | 52 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 125 | - |
dc.citation.endPage | 134 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.identifier.kciid | ART001316629 | - |
dc.identifier.wosid | 000263852600004 | - |
dc.identifier.scopusid | 2-s2.0-79955802670 | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.type.docType | Review | - |
dc.subject.keywordPlus | GLYCOL CHITOSAN NANOPARTICLES | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | PROTEASE ACTIVITY | - |
dc.subject.keywordPlus | PROBE | - |
dc.subject.keywordPlus | ATHEROSCLEROSIS | - |
dc.subject.keywordPlus | VISUALIZATION | - |
dc.subject.keywordPlus | TOMOGRAPHY | - |
dc.subject.keywordAuthor | Bioimaging | - |
dc.subject.keywordAuthor | Multimodality | - |
dc.subject.keywordAuthor | Nanoparticles | - |
dc.subject.keywordAuthor | Activatable | - |
dc.subject.keywordAuthor | Targeting | - |
dc.subject.keywordAuthor | Biodistribution | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.